FP
Schedule 13G filing
Freebird Partners LP disclosed a 7% stake in ERNA
Freebird Partners LP reported owning 7% of Ernexa Therapeutics Inc. (ERNA) (119,015 shares) in a Schedule 13G filed Oct 30, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 30, 2026
- Source
- Schedule 13G
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.